- Home
- WNS vs SPB Comparison
WNS vs SPB Comparison
Compare WNS & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- SPB
- Stock Information
- Founded
- WNS 1996
- SPB 1906
- Country
- WNS India
- SPB United States
- Employees
- WNS N/A
- SPB N/A
- Industry
- WNS Business Services
- SPB Industrial Machinery/Components
- Sector
- WNS Consumer Discretionary
- SPB Miscellaneous
- Exchange
- WNS Nasdaq
- SPB Nasdaq
- Market Cap
- WNS 2.4B
- SPB N/A
- IPO Year
- WNS N/A
- SPB N/A
- Fundamental
- Price
- WNS $66.54
- SPB $71.40
- Analyst Decision
- WNS Buy
- SPB Buy
- Analyst Count
- WNS 9
- SPB 6
- Target Price
- WNS $62.89
- SPB $100.83
- AVG Volume (30 Days)
- WNS 675.2K
- SPB 374.5K
- Earning Date
- WNS 04-24-2025
- SPB 05-08-2025
- Dividend Yield
- WNS N/A
- SPB 2.63%
- EPS Growth
- WNS N/A
- SPB N/A
- EPS
- WNS 2.70
- SPB 4.12
- Revenue
- WNS $1,315,456,000.00
- SPB $2,971,900,000.00
- Revenue This Year
- WNS N/A
- SPB $1.69
- Revenue Next Year
- WNS $7.75
- SPB $2.16
- P/E Ratio
- WNS $24.68
- SPB $17.33
- Revenue Growth
- WNS 1.07
- SPB 2.56
- 52 Week Low
- WNS $39.85
- SPB $68.74
- 52 Week High
- WNS $70.31
- SPB $96.74
- Technical
- Relative Strength Index (RSI)
- WNS 65.11
- SPB 42.56
- Support Level
- WNS $59.70
- SPB $70.13
- Resistance Level
- WNS $70.31
- SPB $72.04
- Average True Range (ATR)
- WNS 2.85
- SPB 1.56
- MACD
- WNS 0.17
- SPB 0.40
- Stochastic Oscillator
- WNS 65.88
- SPB 62.30
Stock Price Comparison Chart: WNS vs SPB
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a Global provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), and South Africa.